Home/Filings/4/0001942459-25-000002
4//SEC Filing

Bornstein Jonathan 4

Accession 0001942459-25-000002

CIK 0001899287other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 7:37 PM ET

Size

7.0 KB

Accession

0001942459-25-000002

Insider Transaction Report

Form 4
Period: 2025-02-21
Bornstein Jonathan
President of Amprius Lab
Transactions
  • Sale

    Common stock

    2025-02-21$3.13/sh13,527$42,383419,197 total
Holdings
  • Common stock

    (indirect: See Footnote)
    1,062,357
Footnotes (5)
  • [F1]This transaction was effected pursuant to non-discretionary, sell-to-cover arrangements mandated by the issuer to fund tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.215, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F3]These securities are restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.
  • [F4]On February 24, 2025, the reporting person transferred 21,407 shares of the issuer's common stock to the Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, for which the reporting person and his spouse are co-trustees.
  • [F5]The securities are held directly by Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, for which the reporting person and his spouse are co-trustees.

Issuer

Amprius Technologies, Inc.

CIK 0001899287

Entity typeother

Related Parties

1
  • filerCIK 0001942459

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 7:37 PM ET
Size
7.0 KB